SI - Mesoblast Chief Executive Silviu Itescu said: “Given the impressive enlargement of the left chamber we
have seen in these children treated with REVASCOR in the randomized controlled trial and the increased
ability to successfully accomplish life-saving surgery, we plan to meet with FDA to discuss the potential
for this trial to support accelerated approval in this indication.”
SI should layout the plan to meet the FDA.
Any idea of
1. Potential Partnership for CHF ?
2. the progresses in the 1Q24?
When is SI meeting with the FDA FOR the Accelerated Approval
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |